Editorial (Thematic Issues: Managing the Cardiovascular Risk Associated with the Metabolic Syndrome)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|31|4941-4943

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.31, 2014-01, pp. : 4941-4943

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Metabolic Syndrome in Pregnancy)

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 7, 2016-05 ,pp. : 572-572

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Syndrome: Cardiovascular Risk Assessment and Management

By Wong Nathan D.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 4, 2007-01 ,pp. : 259-272

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issues: Autoimmunity and Autoinflammation: Cardiovascular Drug Targets and Design)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. : 483-485

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Hot Topic: Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 27, 2013-08 ,pp. : 4797-4798

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Therapy for Cardiovascular Risk Reduction in Patients with the Metabolic Syndrome

By  

Current Pharmaceutical Design, Vol. 20, Iss. 31, 2014-01 ,pp. : 5025-5038

Bentham Science Publishers

Access to resources Recommend Favorite